Alpha-lactalbumin isolated from camel milk on hyperlipidemia and hyperglycemia in experimental mice

This study investigated the effect of alpha-lactalbumin which was isolated from camel milk (a-Lac) at 200 and 400 mcg/day against metabolic disorders hyperlipidemia and hyperglycemia in cholesterol-induced lipidemia for mice. Monitor vital signs such as body weight, fasting glucose in blood level was observed every week until 8 weeks (1st 4wk adaptation and abnormality 2nd, 4wk during treatment investigated period), oral glucose tolerance test (OGTT) level and biochemical parameters were measured after the second 4wk in blood and serum samples, like lipid profiles, insulin resistance, Liver enzymes including ALT, AST, and ALP. The results showed that camel alpha-La contributed effectively to maintaining vital indicators within healthy limits, and caused decreases in the level of hyperlipidemia and hyperglycemia. It gave activity to liver enzymes. The results were a clear statistical difference. Recommend using camel whey proteins and alpha-La in particular due to its abundance in camel milk and its therapeutic properties